Pulmonary function in patients surviving to COVID-19 pneumonia.
Infection
; 49(1): 153-157, 2021 Feb.
Article
in English
| MEDLINE | ID: covidwho-680113
ABSTRACT
PURPOSE:
The aim of our study was to assess respiratory function at the time of clinical recovery and 6 weeks after discharge in patients surviving to COVID-19 pneumonia.METHODS:
Our case series consisted of 13 patients with COVID-19 pneumonia.RESULTS:
At the time of clinical recovery, FEV1 (2.07 ± 0.72 L) and FVC (2.25 ± 0.86 L) were lower compared to lower limit of normality (LLN) values (2.56 ± 0.53 L, p = 0.004, and 3.31 ± 0.65 L, p < 0.001, respectively), while FEV1/FVC (0.94 ± 0.07) was higher compared to upper limit of normality (ULN) values (0.89 ± 0.01, p = 0.029). After 6 weeks pulmonary function improved but FVC was still lower than ULN (2.87 ± 0.81, p = 0.014).CONCLUSION:
These findings suggest that COVID-19 pneumonia may result in clinically relevant alterations in pulmonary function tests, with a mainly restrictive pattern.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cough
/
Dyspnea
/
Fever
/
SARS-CoV-2
/
COVID-19
/
Lung
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Infection
Year:
2021
Document Type:
Article
Affiliation country:
S15010-020-01474-9
Similar
MEDLINE
...
LILACS
LIS